265 related articles for article (PubMed ID: 30356668)
61. [Role of type 2 innate lymphoid cells in helminth infections: a review].
Yang Y; Wang Z; Wu B; Cheng S; Fan H
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Aug; 35(2):184-190. PubMed ID: 37253569
[TBL] [Abstract][Full Text] [Related]
62. IL-33-induced keratoconjunctivitis is mediated by group 2 innate lymphoid cells in mice.
Hosotani Y; Yasuda K; Nagai M; Yamanishi K; Kanazawa N; Gomi F; Imai Y
Allergol Int; 2023 Apr; 72(2):324-331. PubMed ID: 37010996
[TBL] [Abstract][Full Text] [Related]
63. A critical role for c-Myc in group 2 innate lymphoid cell activation.
Ye L; Pan J; Liang M; Pasha MA; Shen X; D'Souza SS; Fung ITH; Wang Y; Patel G; Tang DD; Yang Q
Allergy; 2020 Apr; 75(4):841-852. PubMed ID: 31833571
[TBL] [Abstract][Full Text] [Related]
64. Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion Injury.
Cao Q; Wang Y; Niu Z; Wang C; Wang R; Zhang Z; Chen T; Wang XM; Li Q; Lee VWS; Huang Q; Tan J; Guo M; Wang YM; Zheng G; Yu D; Alexander SI; Wang H; Harris DCH
J Am Soc Nephrol; 2018 Mar; 29(3):961-976. PubMed ID: 29295873
[TBL] [Abstract][Full Text] [Related]
65. HpARI Protein Secreted by a Helminth Parasite Suppresses Interleukin-33.
Osbourn M; Soares DC; Vacca F; Cohen ES; Scott IC; Gregory WF; Smyth DJ; Toivakka M; Kemter AM; le Bihan T; Wear M; Hoving D; Filbey KJ; Hewitson JP; Henderson H; Gonzàlez-Cìscar A; Errington C; Vermeren S; Astier AL; Wallace WA; Schwarze J; Ivens AC; Maizels RM; McSorley HJ
Immunity; 2017 Oct; 47(4):739-751.e5. PubMed ID: 29045903
[TBL] [Abstract][Full Text] [Related]
66. Group 2 Innate Lymphoid Cells Exhibit Tissue-Specific Dynamic Behaviour During Type 2 Immune Responses.
Lok LSC; Walker JA; Jolin HE; Scanlon ST; Ishii M; Fallon PG; McKenzie ANJ; Clatworthy MR
Front Immunol; 2021; 12():711907. PubMed ID: 34484215
[TBL] [Abstract][Full Text] [Related]
67. TLR7 Agonist Suppresses Group 2 Innate Lymphoid Cell-mediated Inflammation via IL-27-Producing Interstitial Macrophages.
Okuzumi S; Miyata J; Kabata H; Mochimaru T; Kagawa S; Masaki K; Irie M; Morita H; Fukunaga K
Am J Respir Cell Mol Biol; 2021 Sep; 65(3):309-318. PubMed ID: 34003734
[TBL] [Abstract][Full Text] [Related]
68. Cytokine-induced endogenous production of prostaglandin D
Maric J; Ravindran A; Mazzurana L; Van Acker A; Rao A; Kokkinou E; Ekoff M; Thomas D; Fauland A; Nilsson G; Wheelock CE; Dahlén SE; Ferreirós N; Geisslinger G; Friberg D; Heinemann A; Konya V; Mjösberg J
J Allergy Clin Immunol; 2019 Jun; 143(6):2202-2214.e5. PubMed ID: 30578872
[TBL] [Abstract][Full Text] [Related]
69. IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms.
Hung LY; Lewkowich IP; Dawson LA; Downey J; Yang Y; Smith DE; Herbert DR
Proc Natl Acad Sci U S A; 2013 Jan; 110(1):282-7. PubMed ID: 23248269
[TBL] [Abstract][Full Text] [Related]
70. BET Bromodomain Inhibitor iBET151 Impedes Human ILC2 Activation and Prevents Experimental Allergic Lung Inflammation.
Kerscher B; Barlow JL; Rana BM; Jolin HE; Gogoi M; Bartholomew MA; Jhamb D; Pandey A; Tough DF; van Oosterhout AJM; McKenzie ANJ
Front Immunol; 2019; 10():678. PubMed ID: 31024538
[TBL] [Abstract][Full Text] [Related]
71. Trained innate lymphoid cells in allergic diseases.
Ebihara T; Tatematsu M; Fuchimukai A; Yamada T; Yamagata K; Takasuga S; Yamada T
Allergol Int; 2021 Apr; 70(2):174-180. PubMed ID: 33328130
[TBL] [Abstract][Full Text] [Related]
72. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
[TBL] [Abstract][Full Text] [Related]
73. ILC2 Proliferated by IL-33 Stimulation Alleviates Acute Colitis in Rag1
You Y; Zhang X; Wang X; Yue D; Meng F; Zhu J; Wang Y; Sun X
J Immunol Res; 2020; 2020():5018975. PubMed ID: 32676507
[TBL] [Abstract][Full Text] [Related]
74. MicroRNA-155 plays critical effects on Th2 factors expression and allergic inflammatory response in type-2 innate lymphoid cells in allergic rhinitis.
Zhu YQ; Liao B; Liu YH; Wang Z; Zhu XH; Chen XB; Wang MQ
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4097-4109. PubMed ID: 31173279
[TBL] [Abstract][Full Text] [Related]
75. Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction.
Rigas D; Lewis G; Aron JL; Wang B; Banie H; Sankaranarayanan I; Galle-Treger L; Maazi H; Lo R; Freeman GJ; Sharpe AH; Soroosh P; Akbari O
J Allergy Clin Immunol; 2017 May; 139(5):1468-1477.e2. PubMed ID: 27717665
[TBL] [Abstract][Full Text] [Related]
76. Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses.
Halim TY; Hwang YY; Scanlon ST; Zaghouani H; Garbi N; Fallon PG; McKenzie AN
Nat Immunol; 2016 Jan; 17(1):57-64. PubMed ID: 26523868
[TBL] [Abstract][Full Text] [Related]
77. The ChAT-acetylcholine pathway promotes group 2 innate lymphoid cell responses and anti-helminth immunity.
Chu C; Parkhurst CN; Zhang W; Zhou L; Yano H; Arifuzzaman M; Artis D
Sci Immunol; 2021 Mar; 6(57):. PubMed ID: 33674322
[TBL] [Abstract][Full Text] [Related]
78. Enforced expression of Gata3 in T cells and group 2 innate lymphoid cells increases susceptibility to allergic airway inflammation in mice.
KleinJan A; Klein Wolterink RG; Levani Y; de Bruijn MJ; Hoogsteden HC; van Nimwegen M; Hendriks RW
J Immunol; 2014 Feb; 192(4):1385-94. PubMed ID: 24415780
[TBL] [Abstract][Full Text] [Related]
79. Alternative activation generates IL-10 producing type 2 innate lymphoid cells.
Seehus CR; Kadavallore A; Torre B; Yeckes AR; Wang Y; Tang J; Kaye J
Nat Commun; 2017 Dec; 8(1):1900. PubMed ID: 29196657
[TBL] [Abstract][Full Text] [Related]
80. Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells.
Duerr CU; McCarthy CD; Mindt BC; Rubio M; Meli AP; Pothlichet J; Eva MM; Gauchat JF; Qureshi ST; Mazer BD; Mossman KL; Malo D; Gamero AM; Vidal SM; King IL; Sarfati M; Fritz JH
Nat Immunol; 2016 Jan; 17(1):65-75. PubMed ID: 26595887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
